News & Views | Published:

Risk factors

Race, renal disease and albuminuria

Nature Reviews Nephrology volume 7, pages 679680 (2011) | Download Citation

A new report suggests that differences in albuminuria might contribute to disparities in susceptibility to nephropathy in African American and white individuals. Interpretation of this finding requires consideration of renal histology, clinical trials and genetic studies. These factors indicate that a far more complex scenario is likely to exist than previously thought.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    et al. Albuminuria and racial disparities in the risk for ESRD. J. Am. Soc. Nephrol. 22, 1721–1728 (2011).

  2. 2.

    , , & APOL1 genotype identifies African Americans at high risk of non-diabetic kidney disease in the Dallas Heart Study. J. Am. Soc. Nephrol. (in press).

  3. 3.

    et al. Ethnic differences in the relationship between albuminuria and calcified atherosclerotic plaque: the African American-Diabetes Heart Study. Diabetes Care 33, 131–138 (2010).

  4. 4.

    & Essential hypertension and risk of nephropathy: a reappraisal. Curr. Opin. Nephrol. Hypertens. 19, 235–241 (2010).

  5. 5.

    et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 13, I80–I93 (1989).

  6. 6.

    , , , & Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group. JAMA 268, 3085–3091 (1992).

  7. 7.

    et al. for the AASK Collaborative Research Group. Intensive blood-pressure control in hypertensive chronic kidney disease. N. Engl. J. Med. 363, 918–929 (2010).

  8. 8.

    et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329, 841–845 (2010).

  9. 9.

    & Genetics of kidney failure and the evolving story of APOL1. J. Clin. Invest. 121, 3367–3374 (2011).

  10. 10.

    et al. The APOL1 gene and allograft survival after kidney transplantation. Am. J. Transplant. 11, 1025–1030 (2011).

Download references

Author information


  1. Department of Internal Medicine, Section on Nephrology, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA

    • Barry I. Freedman
  2. Section on Endocrinology and Metabolism, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA

    • Donald W. Bowden


  1. Search for Barry I. Freedman in:

  2. Search for Donald W. Bowden in:

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Barry I. Freedman.

About this article

Publication history



Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing